StockGlow

TG Therapeutics, Inc. (0VGI.L)

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

$56.70+0.55%
Compare 0VGI.L with
StockGlow Score
97
Bullish
BearishBullish
1 year ago+102.0%

The outlook

TG Therapeutics, Inc. currently reads as bullish based on above its 50- & 200-day averages, 100% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range100% of the way from its 52-week low to high
Market cap
—
52-wk high
$56.70
52-wk low
$6.47
50-day avg
$16.04
200-day avg
$15.15
Trailing P/E
—

Similar stocks

0IUS.LGenie Energy Ltd.$14.21+1.00%0QVL.ILMeren Energy Inc.$13.88+0.87%0MTP.LIDEX Biometrics ASA$8.30-2.35%0J22.LHCI Group, Inc.$174.88-3.79%CASP.LCaspian Sunrise plc$1.90+0.00%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy